Furthermore, through interaction with AR, the transcription factor OCT1 enhances signaling pathways linked to PCa progression, with PFN2 identified as a target gene of OCT1 in AR-negative PCa cells. The gene discussed is PFN2; the disease is posterior cortical atrophy.